The Age-related Macular Degeneration (AMD) drugs market is projected to achieve significant growth, driven by advancements in ophthalmology and increasing awareness of retinal health. With the market estimated to reach $17.37 billion by 2029, stakeholders in pharmaceuticals and healthcare need actionable insights to capitalize on emerging trends.
Market Trends
Advancement in Anti-VEGF...
English
Arabic
Français
Español
Português
Deutsch
Dutch
Italiano
Russian
Romaian